Findings of a new study suggest that changes in the gut microbiome could be linked to Parkinson’s disease and may eventually help researchers identify new underlying mechanisms for the condition.
A new study sheds light on the complex competition and cooperation between bacteria in the gut microbiome. These insights could be leveraged for targeted manipulation of the microbiome.
A new study has identified a way to reshape the gut microbiome that can enhance the delivery of certain chemotherapies to tumors, making these nanoparticle-based cancer drugs more effective.
Bacterial growth could be used for information processing – for example, to predict the severity of an infection. New research results could pave the way for simple and low-cost diagnostic methods.
The presence of certain bacteria in the gut microbiota, and fluctuations in a person’s metabolism, have been identified as potential biomarkers for type 2 diabetes years before its onset.
The microbes living in the human gut influence metabolism, immunity, and cardiovascular health. A new study now suggests they may also be closely connected to Alzheimer's disease.
Changes in gut microbiota after bariatric surgery are strongly linked to altered metabolic health and sustained improvement in type 2 diabetes, according to a new study.
Microbiological cleanliness in laboratories demands far more than routine disinfection – it requires a comprehensive contamination control strategy from the very first design stage. At the Labs Expo trade fair in Poznań, Poland, industry experts Jerzy Kustra and Piotr Caban outlined the most common mistakes organisations make and how to avoid them.
Scientists have discovered the protective role of a bacterium that could prevent long Covid. Their discovery could lead to the development of new therapy approaches.
Antibiotics can affect the composition of the community of bacteria living in the gut, known as the gut microbiome, for as long as four to eight years after treatment, a new study shows.
“The bacteria effectively hide in a bunker”: New research reveals a surprising mechanism used by Acinetobacter baumannii and Pseudomonas aeruginosa to protect themselves from antibiotics.
To better distinguish between healthy and diseased gut microbiomes, scientists have created an index that tracks microbial behavior and signals conditions such as colorectal cancer.
A research team led by the University of Waterloo is developing a novel tool to treat cancer by engineering hungry bacteria to literally eat tumours from the inside out.
A new study shows that analyzing bacteria from vaginal swab samples taken at delivery could help predict the risk of neonatal sepsis.
Reseachers show how Candida albicans – a fungus living in our body – can make melanoma more aggressive. The results pave the way for antifungal therapies to complement skin cancer treatments.
Researchers have uncovered how a high-risk class of genetic vectors can efficiently spread antibiotic resistance within the gut, enabling even highly virulent bacteria to acquire drug resistance.
Chemotherapy does more than kill cancer cells: It reshapes the gut microbiome, making the body less permissive to metastasis. This finding opens new avenues for adjuvant strategies.
With antimicrobial resistance causing over 5 million deaths annually, rapid outbreak detection is critical. A German lab demonstrates how FTIR spectroscopy can transform hospital infection control.
Now, a research team has developed a novel diagnostic approach that enables the rapid and simultaneous detection of both antibiotic resistance and high virulence in Klebsiella pneumoniae.
